Structural and Functional Characterization of Rare Ocular Diseases
NCT ID: NCT05258032
Last Updated: 2022-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2021-11-24
2025-11-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Natural History, Pathogenesis, and Outcome of Ocular Disorders
NCT02821767
Rod and Cone Mediated Function in Retinal Disease
NCT02617966
Natural History of Eye Diseases Related to ABCA4 Mutations
NCT01736293
Stem Cell Models of Best Disease and Other Retinal Degenerative Diseases.
NCT02162953
Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations
NCT07265895
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients able to undergo all required ophthalmic exams
* Patients able and willing to sign an informed consent
Exclusion Criteria
* Patients taking drugs known to affect the retina and/or optic nerve
* Patients that underwent an intraocular surgery (aside from phacoemulsification with intraocular lens implantation), corneal or glaucoma surgery
* Patients who have participated in the past 12 months or that are currently participating in clinical trials for an ocular disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Barcelona Macula Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marc Biarnes Perez
PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut de la màcula
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BarcelonaMaculaF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.